Latest news
FIRST Fund: PHLOX THERAPEUTICS CLOSES SEED INVESTMENT ROUND
16 May 2020, Naarden, The Netherlands - Phlox Therapeutics, a biotech spin-off of the Amsterdam University Medical Center founded by prof. dr. Yigal Pinto and prof. dr. Eva van Rooij, with Margien Boels, PhD as its initiating director of operations have announced the...
BGV Fellowship
Location: Naarden, The Netherlands Duration: 6-9 months About BGV Since our inception in 2006, BGV has raised four early-stage biotech funds totaling over €250 million in capital. Our portfolio is focused on novel therapeutics across different treatment modalities and...
Scenic Biotech and the Barth Syndrome Foundation Announce
Partnership to Explore Genetic Modifiers to a Find Tailored
Treatment for the Complex Rare Disease
Amsterdam, The Netherlands, and Boston, MA, USA - 30 March 2022 - Scenic Biotech BV (‘Scenic’ or ‘the Company’), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other...
Azafaros Announces FDA Grant of Orphan Drug Designation for AZ-3102 in the Treatment of Niemann-Pick Disease
- Second Orphan Drug Designation Supports Azafaros’ Strategy to Develop AZ-3102 as a Disease Modifying Treatment in a Range of Severe Rare Inherited Metabolic Disorders – Leiden, The Netherlands, March 24, 2022 – Azafaros B.V. today announced that the US Food and Drug...
Next events
BioVaria 11-12 May
BioVaria targets technology scouts, business developers and investors highlighting commercially attractive licensing opportunities and promising startups from across Europe. This unique event brings together Europe‘s leading tech transfer professionals, innovators...
Institutional Investment and Venture Capital in The Netherlands 10 May
Dutch Venture Capital is gaining momentum. However, the data shows that Dutch (and European) institutional investors remain underexposed to the Venture Capital asset class relative to their US or Chinese counterparts. On 10 May, BGV Managing Partner Edward van...
Venture Challenge 22 April, 2022
FIRST Fund's Rianne Ellenbroek joins the jury for Venture Challenge taking place on 22 April 2022 in Den Haag. During the Venture Challenge, researchers are guided in setting up a venture plan, in which a scientific breakthrough in the life sciences is converted into...